Review of long-term complications and functional outcomes of ileoanal pouch procedures in patients with inflammatory bowel disease

被引:7
|
作者
Hassan, Yusuf [1 ,4 ]
Connell, William R. [2 ]
Rawal, Alisha [3 ]
Wright, Emily K. [1 ,2 ]
机构
[1] Univ Melbourne, Melbourne Med Sch, Melbourne, Australia
[2] St Vincents Hosp, Dept Gastroenterol, Melbourne, Australia
[3] Grampians Hlth, Gen HMO Stream, Ballarat, Australia
[4] 12 Summit Crescent, Glen Waverley, Vic 3150, Australia
关键词
Crohn's disease; ileoanal pouches; inflammatory bowel disease; pouch failure; pouch fistula; pouchitis; ulcerative colitis; ANAL ANASTOMOSIS; ULCERATIVE-COLITIS; RESTORATIVE PROCTOCOLECTOMY; INCREASED RISK; IPAA; MANAGEMENT; NEOPLASIA; INCREASE; FAILURE; GENDER;
D O I
10.1111/ans.18490
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundIn medically refractory Ulcerative Colitis (UC), proctocolectomy with ileoanal pouch procedure (IAPP) is the preferred continence-preserving surgical option. Functional outcomes post-surgery and long-term complication rates in the biologic era remain ambiguous. This review primarily aims to provide an update on these outcomes. Secondarily, risk factors associated with chronic pouchitis and pouch failure are explored. MethodsTwo online databases (MEDLINE and EMBASE) were searched on 4 October 2022 for English studies from 2011-present relating to long-term outcomes of IAPP in inflammatory bowel disease (IBD) patients. Adult patients with 12 month follow-up were included. Studies focused on 30-day post-operative outcomes, non-IBD patients or studies including less than 30 patients were excluded. ResultsFollowing screening and full-text review of 1094 studies, 49 were included. Median sample size was n = 282 (IQR: 116-519). Median incidences for chronic pouchitis and pouch failure were 17.1% (IQR: 12-23.6%) and 6.9% (IQR: 4.8-10.8%), respectively. Upon multivariate analysis, chronic pouchitis development was most significantly associated with pre-operative steroid use, pancolitis and extra-intestinal IBD manifestations, whilst pouch failure was most significantly associated with pre-operative diagnosis of Crohn's disease (compared to UC), peri-operative pelvic sepsis and anastomotic leak. Overall patient satisfaction was very high with four included studies reporting greater than 90% satisfaction rates. ConclusionLong-term complications for IAPP were common. However, despite this, patient satisfaction post-IAPP was high. Up-to-date knowledge of complication rates and their risk factors improves pre-operative counselling, management planning and patient outcomes.
引用
收藏
页码:1503 / 1509
页数:7
相关论文
共 50 条
  • [31] Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease
    Braga Neto, Manuel B.
    Gregory, Martin H.
    Ramos, Guilherme P.
    Bazerbachi, Fateh
    Bruining, David H.
    Abu Dayyeh, Barham K.
    Kushnir, Vladimir M.
    Raffals, Laura E.
    Ciorba, Matthew A.
    Loftus, Edward V., Jr.
    Deepak, Parakkal
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (07) : 1089 - 1097
  • [32] Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study
    Visuri, Isabella
    Eriksson, Carl
    Karlqvist, Sara
    Lykiardopoulos, Byron
    Karlen, Per
    Grip, Olof
    Soderman, Charlotte
    Almer, Sven
    Hertervig, Erik
    Marsal, Jan
    Malmgren, Carolina
    Delin, Jenny
    Strid, Hans
    Sjoberg, Mats
    Bergemalm, Daniel
    Hjortswang, Henrik
    Halfvarson, Jonas
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [33] Clinical value of surveillance pouchoscopy in asymptomatic ileal pouch patients with underlying inflammatory bowel disease
    Zhu, Hong
    Wu, Xian-rui
    Queener, Elaine
    Kiran, Ravi P.
    Remzi, Feza H.
    Shen, Bo
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2013, 27 (11): : 4325 - 4332
  • [34] Inflammatory bowel disease: long-term therapeutic challenges
    Ashton, James J.
    Green, Zachary
    Kolimarala, Vinod
    Beattie, R. Mark
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (11) : 1049 - 1063
  • [35] An update on the safety of long-term vedolizumab use in inflammatory bowel disease
    Honap, Sailish
    Netter, Patrick
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    EXPERT OPINION ON DRUG SAFETY, 2023,
  • [36] Patient assessment of the long-term benefits of surgery in inflammatory bowel disease
    Medina, C
    Vergara, M
    Casellas, F
    Naval, J
    Lara, F
    Malagelada, JR
    REVISTA CLINICA ESPANOLA, 2000, 200 (09): : 470 - 474
  • [37] Definition of a therapeutic range for predicting long-term infliximab response in patients with inflammatory bowel disease
    Cantarelli, Lorenzo
    Palau, Marta Carrillo
    Guerra, Manuel Hernandez
    Casariego, Gloria Julia Nazco
    Nicolas, Fernando Gutierrez
    MEDICINA CLINICA, 2023, 160 (03): : 107 - 112
  • [38] Lower peripouch fat area is related with increased frequency of pouch prolapse and floppy pouch complex in inflammatory bowel disease patients
    Gao, Xian Hua
    Khan, Freeha
    Yu, Guan Yu
    Li, Jin Qiao
    Chouhan, Hanumant
    Remer, Erick
    Stocchi, Luca
    Hull, Tracy L.
    Shen, Bo
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2020, 35 (04) : 665 - 674
  • [39] Infantile-onset inflammatory bowel disease has variable long-term outcomes
    Krauthammer, Alex
    Weintraub, Ilana
    Shaoul, Ron
    Lev-Tzion, Raffi
    Broide, Efrat
    Wilschanski, Michael
    Lerner, Aaron
    Yerushalmi, Baruch
    Shouval, Dror S.
    Shamaly, Hussein
    Haberman-Ziv, Yael
    Weiss, Batia
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [40] The Incidence of Pouch Neoplasia Following Ileal Pouch-Anal Anastomosis in Patients With Inflammatory Bowel Disease
    Urquhart, Siri A.
    Comstock, Bryce P.
    Jin, Mauricio F.
    Day, Courtney N.
    Eaton, John E.
    Harmsen, William S.
    Raffals, Laura E.
    Loftus, Edward, V
    Coelho-Prabhu, Nayantara
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (02) : 183 - 189